|
Mar 3, 2026 |
Bidas Liat Cohavi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 16, 2026 |
Yeganeh Reuven
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 21, 2025 |
Apr 23, 2025 |
Flynn James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Merril Gregory Louis
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Bassan Merav
|
Chief Development Officer |
Neutral |
90.0
|
+79,597
|
100.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
90.0
|
+126,748
|
100.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
GOODMAN JESSE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Williams Eddie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Moses Alan Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
LEFF JONATHAN S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Blum Susan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Greig Russell
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 21, 2025 |
Wolfson Marina
|
CFO |
Neutral |
90.0
|
+68,545
|
100.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Flynn James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Wolfson Marina
|
CFO |
Neutral |
90.0
|
+68,545
|
100.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Greig Russell
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Merril Gregory Louis
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
LEFF JONATHAN S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
GOODMAN JESSE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Bassan Merav
|
Chief Development Officer |
Neutral |
90.0
|
+79,597
|
100.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Williams Eddie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Moses Alan Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
90.0
|
+126,748
|
100.00%
|
✗
|
- |
| Apr 14, 2025 |
Apr 18, 2025 |
Blum Susan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 4, 2025 |
Cystic Fibrosis Foundation
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Mar 4, 2025 |
Cystic Fibrosis Foundation
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2025 |
Mar 3, 2025 |
Flynn James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 16, 2024 |
Sep 18, 2024 |
Bassan Merav
|
Chief Development Officer |
Neutral |
90.0
|
+31,749
|
100.00%
|
✗
|
- |
| Sep 16, 2024 |
Sep 18, 2024 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
90.0
|
+50,556
|
2022.24%
|
✗
|
- |
| Sep 16, 2024 |
Sep 18, 2024 |
Oron Assaf
|
Chief Business Officer |
Neutral |
90.0
|
+25,804
|
100.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Flynn James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Flynn James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Blum Susan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Greig Russell
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Bassan Merav
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Wolfson Marina
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
LEFF JONATHAN S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
GOODMAN JESSE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Merril Gregory Louis
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Williams Eddie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Oron Assaf
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 15, 2024 |
Moses Alan Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 9, 2024 |
Jul 11, 2024 |
Flynn James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 20, 2024 |
OrbiMed Israel BioFund GP Limited Partnership
|
10% Owner |
Sell |
52.5
|
-24,344
|
-0.18%
|
✗
|
$9.3K |
| May 15, 2024 |
May 17, 2024 |
Cystic Fibrosis Foundation
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 15, 2024 |
Blum Susan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 26, 2024 |
Cystic Fibrosis Foundation
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 21, 2024 |
LEFF JONATHAN S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 21, 2024 |
Merril Gregory Louis
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 21, 2024 |
GOODMAN JESSE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Flynn James E
|
Director |
Neutral |
90.0
|
+6,110,098
|
100.00%
|
✗
|
- |
|
Mar 19, 2024 |
Flynn James E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
OrbiMed Israel BioFund GP Limited Partnership
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2023 |
Dec 13, 2023 |
Wolfson Marina
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2023 |
Dec 13, 2023 |
Bassan Merav
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2023 |
Dec 13, 2023 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2023 |
Dec 13, 2023 |
Oron Assaf
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 11, 2023 |
Gabay Avraham
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 29, 2023 |
Dec 1, 2023 |
Oron Assaf
|
Chief Business Officer |
Sell |
27.5
|
-10,914
|
-100.00%
|
✗
|
$4.1K |
| Oct 29, 2023 |
Oct 31, 2023 |
Bassan Merav
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 29, 2023 |
Oct 31, 2023 |
Wolfson Marina
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 29, 2023 |
Oct 31, 2023 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 29, 2023 |
Oct 31, 2023 |
Oron Assaf
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 19, 2023 |
Oct 23, 2023 |
Williams Eddie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 18, 2023 |
Williams Eddie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 21, 2023 |
Aug 23, 2023 |
Marks Jason M.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 21, 2023 |
Aug 23, 2023 |
Dambach Michael E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2023 |
May 24, 2023 |
Oron Assaf
|
Chief Business Officer |
Buy |
90.0
|
+3,192
|
41.34%
|
✗
|
$871.7 |
| May 18, 2023 |
May 22, 2023 |
Oron Assaf
|
Chief Business Officer |
Buy |
90.0
|
+7,722
|
100.00%
|
✗
|
$2.2K |
|
May 19, 2023 |
Marks Jason M.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 19, 2023 |
Dambach Michael E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2023 |
Mar 17, 2023 |
OrbiMed Israel BioFund GP Limited Partnership
|
10% Owner |
Buy |
95.0
|
+348,000
|
12.37%
|
✗
|
$85.3K |
| Mar 1, 2023 |
Mar 3, 2023 |
Greig Russell
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2023 |
Mar 3, 2023 |
Moses Alan Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2023 |
Mar 3, 2023 |
Bassan Merav
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2023 |
Mar 3, 2023 |
Wolfson Marina
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2023 |
Mar 3, 2023 |
Sullivan Lynne Marie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2023 |
Mar 3, 2023 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2023 |
Mar 3, 2023 |
Oron Assaf
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 17, 2022 |
Nov 14, 2022 |
Ugwumba Chidozie
|
Other |
Sell |
26.3
|
-74,955
|
-2.44%
|
✗
|
$26.6K |
| Sep 16, 2022 |
Nov 14, 2022 |
Ugwumba Chidozie
|
Other |
Sell |
22.5
|
-277,247
|
-8.28%
|
✗
|
$107.2K |
| Aug 10, 2022 |
Nov 14, 2022 |
Ugwumba Chidozie
|
Other |
Sell |
40.0
|
-288,619
|
-0.33%
|
✗
|
$184.2K |
| Aug 22, 2022 |
Aug 24, 2022 |
Wolfson Marina
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 22, 2022 |
Aug 24, 2022 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 22, 2022 |
Aug 24, 2022 |
Bassan Merav
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
Greig Russell
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
Moses Alan Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
Bassan Merav
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
Wolfson Marina
|
SVP of Finance & Operations |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
Sullivan Lynne Marie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
Solomon Jonathan Eitan
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
GROSSMAN JONAS
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2022 |
Mar 31, 2022 |
Amusa Gbolahan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 31, 2021 |
Feb 14, 2022 |
Walton Thomas Layton
|
10% Owner |
Neutral |
27.5
|
-3,637,846
|
-100.00%
|
✗
|
- |
|
Feb 14, 2022 |
Ugwumba Chidozie
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 26, 2021 |
Aug 17, 2021 |
GROSSMAN JONAS
|
Director |
Neutral |
90.0
|
+37,500
|
11.19%
|
✗
|
- |
|
Aug 9, 2021 |
Walton Thomas Layton
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 28, 2021 |
Jul 30, 2021 |
OrbiMed Israel BioFund GP Limited Partnership
|
10% Owner |
Neutral |
90.0
|
+500,000
|
21.61%
|
✗
|
- |
| Jul 28, 2021 |
Jul 30, 2021 |
Wolfson Marina
|
SVP of Finance & Operations |
Buy |
91.3
|
+3,750
|
100.00%
|
✗
|
$15K |